Literature DB >> 20462676

Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection.

Joshua Lubek1, Michel El-Hakim, Andrew R Salama, Xinggang Liu, Robert A Ord.   

Abstract

Gingival squamous cell carcinoma (SCC) is relatively uncommon, and little is known about its metastatic pattern. We retrospectively reviewed 864 consecutive patients with oral SCC who were seen at the University of Maryland Department of Oral and Maxillofacial Surgery (1991-2005), and identified 111 cases of gingival SCC. Inclusion criteria were fulfilled in 72 patients (mean duration of follow up 49 (1-153) months). Mean (range) age was 72 (45-93) years; 41 patients were women and 31 men. Distribution was almost equal: mandible 35 and maxilla 37. Forty (56%) were in the early stages (pI/II) and 32 (44%) in the later stages (pIII/IV). Twenty-nine patients had primary neck dissections, of whom 7/21 had clear, and 6/8 invaded, cervical nodes. The total number of occult nodal metastases was 9/29 (31%) in the mandible and 14/35 in the maxilla (one patient with initially clear nodes had both invaded nodes at neck dissection and a recurrence in the neck). The number of early compared with late stage occult metastases was 4 of 20 patients (20% T1/T2) and 5 of 9 patients (55% T3/T4) in the mandible and 2 of 22 patients (9% T1/T2) and 2 of 13 patients (15% T3/T4) in the maxilla. Two of 9 patients developed occult nodes within T2 maxillary gingival SCC. Bony invasion was identified in 17 patients (24%) occurring in 8 of 19 patients (42%) with invaded nodes compared with 9 of 53 patients (17%) with clear nodes. Overall survival at 2 and 5 years was 53 of 72 patients (74%) and 27 of 72 patients (38%) respectively. Elective neck dissection is indicated for all stages of mandibular gingival tumours and T3/T4 carcinomas of the maxillary gingiva. T2 maxillary SCC should be considered for elective neck dissection. Overall disease-free survival was worse among those with cervical metastases (p=0.004) and those who had had marginal resections (p=0.04).
Copyright © 2010 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20462676     DOI: 10.1016/j.bjoms.2010.04.005

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  18 in total

Review 1.  Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

Authors:  R A Ord
Journal:  Oral Maxillofac Surg       Date:  2012-05-13

Review 2.  Cancer of the gingiva.

Authors:  Rusana Bark; Claes Mercke; Eva Munck-Wikland; Natalie Ann Wisniewski; Lalle Hammarstedt-Nordenvall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-04       Impact factor: 2.503

3.  Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva.

Authors:  Tatsuhiko Nakasato; Mitsuru Izumisawa; Akio Akahane; Koyo Kikuchi; Shigeru Ehara; Satoru Shoji; Shintaro Kogi; Harumi Mizuki; Yoshiki Sugiyama
Journal:  Jpn J Radiol       Date:  2012-09-01       Impact factor: 2.374

4.  Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.

Authors:  Gustavo Davi Rabelo; Claudia Coutinho-Camillo; Luiz Paulo Kowalski; Nathalie Portero-Muzy; Jean-Paul Roux; Pascale Chavassieux; Fabio Abreu Alves
Journal:  Clin Oral Investig       Date:  2017-06-24       Impact factor: 3.573

5.  Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.

Authors:  A Kolk; T Schuster; A Chlebowski; P Lange; K Scheidhauer; M Kesting; O Bissinger; M Schwaiger; J Dinges; J Weitz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-27       Impact factor: 9.236

6.  Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.

Authors:  Y Mukai; M Hata; K Mitsudo; I Koike; T Koizumi; S Oguri; M Kioi; M Omura; I Tohnai; T Inoue
Journal:  Strahlenther Onkol       Date:  2013-11-23       Impact factor: 3.621

7.  Elective neck dissection versus observation in early stage oral squamous cell carcinoma: recurrence and survival.

Authors:  Dong Wook Kim; Ba-Da Lee; Jung Hwan Lim; Jung-Hyun Park; Woong Nam; Hyung Jun Kim; In-Ho Cha
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-12-27

8.  Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts.

Authors:  Jingjing Quan; Moustafa Elhousiny; Newell W Johnson; Jin Gao
Journal:  Clin Exp Metastasis       Date:  2013-02-02       Impact factor: 5.150

9.  Gingival squamous cell carcinoma: a case report.

Authors:  Luiz Antonio Guimarães Cabral; Luis Felipe das Chagas E Silva de Carvalho; José Antônio Pereira Salgado; Adriana Aigotti Haberbeck Brandão; Janete Dias Almeida
Journal:  J Oral Maxillofac Res       Date:  2010-10-01

10.  Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma.

Authors:  Masaya Okura; Souichi Yanamoto; Masahiro Umeda; Mitsunobu Otsuru; Yoshihide Ota; Hiroshi Kurita; Takahiro Kamata; Tadaaki Kirita; Nobuhiro Yamakawa; Tetsuro Yamashita; Michihiro Ueda; Takahide Komori; Takumi Hasegawa; Tomonao Aikawa
Journal:  Cancer Med       Date:  2016-10-19       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.